Focal epilepsy (localisation-related) management
Focal-onset seizures · Neurology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Focal-onset epilepsy arising from a discrete cortical region, commonly temporal lobe, presenting with focal aware, focal impaired-awareness or focal-to-bilateral tonic-clonic seizures. Requires structural imaging and tailored sodium-channel or broad-spectrum medication.
Red flags
- Progressive focal deficit or new lesion on imaging
- Drug-resistant seizures despite two appropriate agents
- Frequent focal-to-bilateral tonic-clonic seizures
- Suicidal ideation on antiseizure medication
- Status epilepticus
Assessment
Differential diagnosis
- Genetic generalised epilepsy
- Psychogenic non-epileptic seizures
- Syncope with convulsive movements
- Transient ischaemic attack
- Panic attacks or dissociative episodes
- Hypoglycaemia or metabolic events
Investigations
- MRI brain with epilepsy protocol (hippocampal views) to seek structural lesion
- Interictal EEG for focal epileptiform discharges
- Prolonged or sleep-deprived EEG if diagnosis uncertain
- ECG to exclude cardiac syncope
- Bloods including glucose, electrolytes, calcium
- Video-EEG telemetry if diagnosis or localisation unclear
Management
- Confirm focal semiology (automatisms, deja vu, rising epigastric sensation, focal motor signs)
- Image with MRI to identify mesial temporal sclerosis, cortical dysplasia or tumour
- Classify seizure type and estimate recurrence risk before starting therapy
- Offer first-line monotherapy with lamotrigine or levetiracetam per current guidance
- Titrate slowly to lowest effective dose and reassess seizure diary
- Add or switch to alternative agent if first drug fails at adequate dose
- Screen for and manage mood disorder and medication adverse effects
- Give driving, safety, alcohol and sleep advice
- Identify drug-resistant epilepsy early (failure of two tolerated appropriate drugs)
- Refer drug-resistant cases for epilepsy surgery evaluation
Drugs & doses
Lamotrigine 25 mg PO daily, titrate over weeks to 100-200 mg BD
Levetiracetam 250-500 mg PO BD, titrate to 1000-1500 mg BD
Lacosamide 50 mg PO BD, titrate to 100-200 mg BD
Carbamazepine 100-200 mg PO BD, titrate to 400-600 mg BD
Zonisamide 50 mg PO daily, titrate to 100-300 mg daily
Brivaracetam 25-50 mg PO BD as alternative
Disposition
Outpatient epilepsy clinic. Refer drug-resistant focal epilepsy to a tertiary epilepsy surgery centre for video-EEG and presurgical evaluation.
Complications & pitfalls
- Drug resistance in up to a third of patients
- Memory and mood impairment (temporal lobe involvement)
- Injury from focal-to-bilateral tonic-clonic seizures
- SUDEP
- Medication interactions and adverse effects
Exam pearls
- Identify drug-resistant epilepsy early and refer for surgical workup rather than cycling endless drugs
- Mesial temporal sclerosis is a surgically remediable cause
- Enzyme-inducing drugs (carbamazepine) reduce efficacy of hormonal contraception and many drugs
- Screen for depression which is common and under-treated
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.